These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 17454955

  • 1. Evaluation of atrial and brain natriuretic polypeptides in association with angiotensin-converting enzyme gene polymorphism in Japanese non-diabetic hemodialysis patients.
    Nakao K, Kuze K, Abe H, Takahashi T, Doi T.
    Scand J Urol Nephrol; 2007; 41(2):149-54. PubMed ID: 17454955
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A, Okazaki M, Kato H, Anai H, Tsuda Y, Segawa K, Tanaka H, Tamura M, Takasugi M, Nakashima Y.
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [Abstract] [Full Text] [Related]

  • 3. [Clinical significance of plasma atrial and brain natriuretic peptide levels during hemodialysis in hemodialysis patients with old myocardial infarction].
    Uetake S, Takahashi M, Tamano K, Honda T, Kobayashi T, Horinaka S.
    J Cardiol; 2001 Aug; 38(2):61-71. PubMed ID: 11525111
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of long axis M-mode echocardiographic measurements for optimum dialysis in patients on maintenance hemodialysis: comparison with changes in plasma levels of atrial natriuretic peptide and brain natriuretic peptide.
    Sugihara K, Fujimoto S, Motomiya Y, Hashimoto T, Nakamura S, Dohi K.
    Clin Nephrol; 2001 Aug; 56(2):140-9. PubMed ID: 11522091
    [Abstract] [Full Text] [Related]

  • 5. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R, Banach M, Piechota M, Kowalski J, Barylski M, Cierniewski C, Pawlicki L.
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction.
    Palmer BR, Pilbrow AP, Yandle TG, Frampton CM, Richards AM, Nicholls MG, Cameron VA.
    J Am Coll Cardiol; 2003 Mar 05; 41(5):729-36. PubMed ID: 12628714
    [Abstract] [Full Text] [Related]

  • 7. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene is associated with atrial natriuretic peptide activity after exercise.
    Friedl W, Mair J, Pichler M, Paulweber B, Sandhofer F, Puschendorf B.
    Clin Chim Acta; 1998 Jun 22; 274(2):199-211. PubMed ID: 9694588
    [Abstract] [Full Text] [Related]

  • 8. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease.
    Nishikimi T, Futoo Y, Tamano K, Takahashi M, Suzuki T, Minami J, Honda T, Uetake S, Asakawa H, Kobayashi N, Horinaka S, Ishimitsu T, Matsuoka H.
    Am J Kidney Dis; 2001 Jun 22; 37(6):1201-8. PubMed ID: 11382689
    [Abstract] [Full Text] [Related]

  • 9. Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease.
    Osajima A, Okazaki M, Tamura M, Anai H, Kabashima N, Suda T, Iwamoto M, Ota T, Watanabe Y, Kanegae K, Nakashima Y.
    Nephron; 2002 Dec 22; 92(4):832-9. PubMed ID: 12399629
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin-converting enzyme gene polymorphism and cardiovascular endocrine system in coronary angiography patients.
    Tsukada K, Ishimitsu T, Tsuchiya N, Horinaka S, Matsuoka H.
    Jpn Heart J; 1997 Nov 22; 38(6):799-810. PubMed ID: 9486933
    [Abstract] [Full Text] [Related]

  • 11. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
    Falcão LM, Pinto F, Ravara L, van Zwieten PA.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep 22; 5(3):121-9. PubMed ID: 15526247
    [Abstract] [Full Text] [Related]

  • 12. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
    Kohno M, Yokokawa K, Minami M, Kano H, Yasunari K, Hanehira T, Yoshikawa J.
    Am J Med; 1999 May 22; 106(5):544-9. PubMed ID: 10335726
    [Abstract] [Full Text] [Related]

  • 13. The concentration of atrial and brain natriuretic peptide in patients with idiopathic hypertension.
    Irzmanski R, Barylski M, Banach M, Piechota M, Kowalski J, Cierniewski C, Pawlicki L.
    Med Sci Monit; 2007 Oct 22; 13(10):CR449-56. PubMed ID: 17901852
    [Abstract] [Full Text] [Related]

  • 14. The mature form of adrenomedullin correlates with brain natriuretic peptide in plasma of chronic hemodialysis patients.
    Suda T, Osajima A, Iwamoto M, Anai H, Tamura M, Kabashima N, Ota T, Watanabe Y, Kanegae K, Okazaki M, Nakashima Y.
    Clin Nephrol; 2002 Jun 22; 57(6):444-51. PubMed ID: 12078948
    [Abstract] [Full Text] [Related]

  • 15. Effect of angiotensin-converting enzyme gene polymorphism on left ventricular remodeling after anteroseptal infarction.
    Nagashima J, Musha H, So T, Kunishima T, Nobuoka S, Murayama M.
    Clin Cardiol; 1999 Sep 22; 22(9):587-90. PubMed ID: 10486698
    [Abstract] [Full Text] [Related]

  • 16. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
    Gwechenberger M, Huelsmann M, Graf S, Berger R, Bonderman D, Stanek B, Rauscha F, Pacher R.
    Eur J Clin Invest; 2004 Dec 22; 34(12):811-7. PubMed ID: 15606723
    [Abstract] [Full Text] [Related]

  • 17. [ACE gene polymorphism correlation (I/D) with the ventricular function in patients with ischemic and idiopathic dilated cardiomyopathy].
    Avila-Vanzzini N, Espínola-Zavaleta N, Masso-Rojas F, Varela-López E, Casanova-Garcés JM, Kury-Alfaro J, Herrera-Bello H.
    Rev Invest Clin; 2006 Dec 22; 58(1):39-46. PubMed ID: 16789598
    [Abstract] [Full Text] [Related]

  • 18. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
    Cataliotti A, Malatino LS, Jougasaki M, Zoccali C, Castellino P, Giacone G, Bellanuova I, Tripepi R, Seminara G, Parlongo S, Stancanelli B, Bonanno G, Fatuzzo P, Rapisarda F, Belluardo P, Signorelli SS, Heublein DM, Lainchbury JG, Leskinen HK, Bailey KR, Redfield MM, Burnett JC.
    Mayo Clin Proc; 2001 Nov 22; 76(11):1111-9. PubMed ID: 11702899
    [Abstract] [Full Text] [Related]

  • 19. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.
    Haug C, Metzele A, Steffgen J, Grünert A.
    Horm Metab Res; 1994 May 22; 26(5):246-9. PubMed ID: 8076909
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin-converting enzyme genotype modulates pulmonary function and exercise capacity in treated patients with congestive stable heart failure.
    Abraham MR, Olson LJ, Joyner MJ, Turner ST, Beck KC, Johnson BD.
    Circulation; 2002 Oct 01; 106(14):1794-9. PubMed ID: 12356632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.